News & Updates

Show Multimedia Only

Mediterranean, plant-based diets vital in MASLD management

12 Jan 2026 by

Dietary interventions continue to provide benefits in the management of chronic liver diseases and serve as a valuable addition to pharmacotherapy options available, reports a study.

Mediterranean, plant-based diets vital in MASLD management

12 Jan 2026

Long-term use of mirikizumab does not raise new safety signals

11 Jan 2026 by

A recent study has demonstrated the long-term safety of mirikizumab in patients with moderate to severe active ulcerative colitis (UC), with no new significant safety concerns.

Long-term use of mirikizumab does not raise new safety signals

11 Jan 2026

Which social determinant predicts MASLD prevalence, severity?

08 Jan 2026

Among several social determinants of health (SDOHs), diet quality is most consistently associated with disease prevalence and severity in metabolic dysfunction-associated steatotic liver disease (MASLD), reports a study.

Which social determinant predicts MASLD prevalence, severity?

08 Jan 2026

Mortality risk elevated in UC patients with CAD

07 Jan 2026 by

Ulcerative colitis (UC) patients with active coronary artery disease (CAD) appear to be at greater risk of mortality than those with Crohn’s disease (CD), suggest the results of a study presented at AIBD 2025.

Mortality risk elevated in UC patients with CAD

07 Jan 2026

Long-term anti-TNF use works wonders in moderate to severe IBD

07 Jan 2026 by

The use of antitumour necrosis factor (anti-TNF) agents for at least 60 months is not only safe but also effective in the treatment of moderate to severe inflammatory bowel disease (IBD), according to a study presented at AIBD 2025.

Long-term anti-TNF use works wonders in moderate to severe IBD

07 Jan 2026

Is yoga good for people with IBS?

07 Jan 2026

Yoga does not appear helpful in reducing gastrointestinal severity of symptoms, anxiety, and depression or quality of life in patients with irritable bowel syndrome (IBS), a study has shown.

Is yoga good for people with IBS?

07 Jan 2026

4-week ustekinumab dosing revs up response in Crohn’s disease

05 Jan 2026 by

For Crohn’s disease (CD) patients with suboptimal response to ustekinumab, doubling the dosing frequency from every 8 weeks to every 4 weeks elicited meaningful improvements in objective and patient-reported outcomes, as shown in a small retrospective study.

4-week ustekinumab dosing revs up response in Crohn’s disease

05 Jan 2026

Real-world study supports high-dose IV iron for IBD-associated anaemia

05 Jan 2026 by

Real-world evidence shows the efficacy and safety of high-dose intravenous (IV) iron for the treatment of anaemia in individuals with inflammatory bowel disease (IBD), irrespective of inflammatory activity.

Real-world study supports high-dose IV iron for IBD-associated anaemia

05 Jan 2026

Yoga of little benefit in IBS

05 Jan 2026

For patients with irritable bowel syndrome (IBS), practicing yoga does not help improve symptoms, anxiety, depression, and quality of life, according to a systematic review and meta-analysis.

Yoga of little benefit in IBS

05 Jan 2026

$Younger women with IBD prone to hip fractures$

Younger women with IBD prone to hip fractures

02 Jan 2026 by

Female sex appears to be an independent risk factor for hip fracture among individuals with inflammatory bowel disease (IBD), findings from a nationally representative study suggest.

Younger women with IBD prone to hip fractures

02 Jan 2026

News & Updates

Showing Gastroenterology articles

Showing

Specialty:

Mediterranean, plant-based diets vital in MASLD management

Mediterranean, plant-based diets vital in MASLD management

Long-term use of mirikizumab does not raise new safety signals

Long-term use of mirikizumab does not raise new safety signals

Which social determinant predicts MASLD prevalence, severity?

Which social determinant predicts MASLD prevalence, severity?

Mortality risk elevated in UC patients with CAD

Mortality risk elevated in UC patients with CAD

Long-term anti-TNF use works wonders in moderate to severe IBD

Long-term anti-TNF use works wonders in moderate to severe IBD

Is yoga good for people with IBS?

Is yoga good for people with IBS?

4-week ustekinumab dosing revs up response in Crohn’s disease

4-week ustekinumab dosing revs up response in Crohn’s disease

Real-world study supports high-dose IV iron for IBD-associated anaemia

Real-world study supports high-dose IV iron for IBD-associated anaemia

Yoga of little benefit in IBS

Yoga of little benefit in IBS

Younger women with IBD prone to hip fractures

Younger women with IBD prone to hip fractures